Compare ADUS & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADUS | ATRC |
|---|---|---|
| Founded | 1979 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.4B |
| IPO Year | 2009 | 2005 |
| Metric | ADUS | ATRC |
|---|---|---|
| Price | $93.52 | $28.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 7 |
| Target Price | ★ $135.40 | $51.17 |
| AVG Volume (30 Days) | 168.5K | ★ 500.0K |
| Earning Date | 05-04-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 23.40 | ★ 74.74 |
| EPS | ★ 5.22 | N/A |
| Revenue | N/A | ★ $201,630,000.00 |
| Revenue This Year | $9.17 | $15.17 |
| Revenue Next Year | $4.64 | $12.42 |
| P/E Ratio | $18.08 | ★ N/A |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $93.86 | $28.16 |
| 52 Week High | $124.44 | $43.18 |
| Indicator | ADUS | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 27.03 | 36.13 |
| Support Level | N/A | N/A |
| Resistance Level | $118.51 | $38.25 |
| Average True Range (ATR) | 2.91 | 1.11 |
| MACD | -0.53 | 0.13 |
| Stochastic Oscillator | 2.19 | 27.35 |
Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.